Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $2.08 billion. The enterprise value is $1.78 billion.
| Market Cap | 2.08B |
| Enterprise Value | 1.78B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 61.11 million shares outstanding. The number of shares has increased by 8.22% in one year.
| Shares Outstanding | 61.11M |
| Shares Change (YoY) | +8.22% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 102.81% |
| Float | 40.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.41 |
| Forward PS | 38.21 |
| PB Ratio | 5.26 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.21.
| Current Ratio | 4.73 |
| Quick Ratio | 4.62 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -748.81 |
Financial Efficiency
Return on equity (ROE) is -34.80% and return on invested capital (ROIC) is -34.51%.
| Return on Equity (ROE) | -34.80% |
| Return on Assets (ROA) | -25.30% |
| Return on Capital (ROIC) | -34.51% |
| Revenue Per Employee | $420,278 |
| Profits Per Employee | -$785,893 |
| Employee Count | 187 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.74% in the last 52 weeks. The beta is 2.27, so KYMR's price volatility has been higher than the market average.
| Beta (1Y) | 2.27 |
| 52-Week Price Change | -1.74% |
| 50-Day Moving Average | 39.01 |
| 200-Day Moving Average | 25.35 |
| Relative Strength Index (RSI) | 37.74 |
| Average Volume (30 Days) | 667,817 |
Short Selling Information
The latest short interest is 9.06 million, so 14.83% of the outstanding shares have been sold short.
| Short Interest | 9.06M |
| Short Previous Month | 8.33M |
| Short % of Shares Out | 14.83% |
| Short % of Float | 22.61% |
| Short Ratio (days to cover) | 12.90 |
Income Statement
In the last 12 months, KYMR had revenue of $78.59 million and -$146.96 million in losses. Loss per share was -$2.52.
| Revenue | 78.59M |
| Gross Profit | 78.59M |
| Operating Income | -165.53M |
| Pretax Income | -146.96M |
| Net Income | -146.96M |
| EBITDA | -143.20M |
| EBIT | -146.77M |
| Loss Per Share | -$2.52 |
Balance Sheet
The company has $380.69 million in cash and $84.67 million in debt, giving a net cash position of $296.02 million or $4.84 per share.
| Cash & Cash Equivalents | 380.69M |
| Total Debt | 84.67M |
| Net Cash | 296.02M |
| Net Cash Per Share | $4.84 |
| Equity / Book Value | 394.97M |
| Book Value Per Share | 6.46 |
| Working Capital | 319.63M |
Cash Flow
In the last 12 months, operating cash flow was -$102.83 million and capital expenditures -$34.48 million, giving a free cash flow of -$137.31 million.
| Operating Cash Flow | -102.83M |
| Capital Expenditures | -34.48M |
| Free Cash Flow | -137.31M |
| FCF Per Share | -$2.35 |
Margins
Gross margin is 100.00%, with operating and profit margins of -210.62% and -186.99%.
| Gross Margin | 100.00% |
| Operating Margin | -210.62% |
| Pretax Margin | -186.99% |
| Profit Margin | -186.99% |
| EBITDA Margin | -182.21% |
| EBIT Margin | -186.74% |
| FCF Margin | -174.71% |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.22% |
| Shareholder Yield | -8.22% |
| Earnings Yield | -7.08% |
| FCF Yield | -6.61% |
Analyst Forecast
The average price target for KYMR is $39.70, which is 16.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.70 |
| Price Target Difference | 16.87% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 29.44% |
| EPS Growth Forecast (5Y) | -16.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 5.56 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.56 |
| Piotroski F-Score | 2 |